CLINICAL IMPACT OF HARM REDUCTION IN PATIENTS WITH CHRONIC LIVER DISEASE AND ALCOHOL USE DISORDER BY BRIEF INTERVENTION IN A HEPATOLOGY OUTPATIENT UNIT

被引：0

作者：

Hara, Nagisa ^{[1
]}

Hiraoka, Atsushi ^{[2
]}

Nakai, Masato ^{[3
]}

Shiraki, Makoto ^{[4
]}

Namisaki, Tadashi ^{[5
]}

Miyaaki, Hisamitsu ^{[6
]}

Hisanaga, Takuro ^{[7
]}

Takahashi, Hirokazu ^{[1
]}

Ohama, Hideko ^{[2
]}

Tada, Fujimasa ^{[2
]}

Sakamoto, Naoya ^{[8
]}

Nakao, Kazuhiko ^{[6
]}

Takami, Taro ^{[7
]}

Eguchi, Yuichiro ^{[9
]}

Yoshiji, Hitoshi ^{[10
]}

机构：

[1] Saga Univ Hosp, Saga, Japan

[2] Ehime Prefectural Cent Hosp, Matsuyama, Ehime, Japan

[3] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan

[4] Chuno Kosei Hosp, Seki, Japan

[5] Nara Med Univ Hosp, Kashihara, Nara, Japan

[6] Nagasaki Univ Hosp, Nagasaki, Japan

[7] Yamaguchi Univ, Yamaguchi, Japan

[8] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan

[9] Loco Med Gen Inst, Saga, Japan

[10] Nara Med Univ, Kashihara, Nara, Japan

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1458

引用

页码：S1106 / S1106

页数：1

共 50 条

[21] Impact of Harm Reduction Treatment with or without Pharmacotherapy on Polysubstance Use among People Experiencing Homelessness and Alcohol Use Disorder
Mostofi, Nicole
Collins, Susan E.
JOURNAL OF ADDICTION MEDICINE, 2023, 17 (05) : 574 - 579
[22] SUBSTANCE USE DISORDER ASSOCIATES WITH AN ELEVATED RISK OF ALCOHOL-ASSOCIATED LIVER DISEASE IN PATIENTS WITH ALCOHOL USE DISORDER
Vannier, Augustin
Fomin, Vladislav
Marshall, Chantelle
Goodman, Russell
Schaefer, Esperance
Luther, Jay
HEPATOLOGY, 2021, 74 : 255A - 255A
[23] Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease
Leko, Andras H.
Leggio, Lorenzo
CLINICS IN LIVER DISEASE, 2024, 28 (04) : 779 - 791
[24] Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease
Nielsen, Jon Kristinn
Olafsson, Sigurdur
Bergmann, Ottar M.
Runarsdottir, Valgerdur
Hansdottir, Ingunn
Sigurdardottir, Ragna
Bjornsson, Einar S.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (6-7) : 762 - 767
[25] Impact of minimum price per unit of alcohol on patients with liver disease in the UK
Sheron, Nick
Chilcott, Fern
Matthews, Laura
Challoner, Ben
Thomas, Maria
CLINICAL MEDICINE, 2014, 14 (04) : 396 - 403
[26] The effectiveness of a brief intervention for intensive care unit patients with hazardous alcohol use: a randomized controlled trial
Nissila, Eliisa
Hynninen, Marja
Jalkanen, Ville
Kuitunen, Anne
Backlund, Minna
Inkinen, Outi
Hastbacka, Johanna
CRITICAL CARE, 2024, 28 (01)
[27] Computer-delivered brief alcohol intervention for patients with liver disease: a randomized controlled trial
Cucciare, Michael A.
Combs, Ann S.
Joshi, Gauri
Han, Xiaotong
Humphreys, Keith
ADDICTION, 2021, 116 (05) : 1076 - 1087
[28] Alcohol use in patients with newly diagnosed chronic liver disease.
Navarro, VJ
St Louis, TE
Benner, KG
Zaman, A
Ivie, KB
Bell, BP
HEPATOLOGY, 2000, 32 (04) : 424A - 424A
[29] Impact of harm reduction treatment with or without pharmacotherapy on concurrent substance use among people experiencing homelessness and alcohol use disorder
Mostofi, N. D.
Collins, S. E.
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 556 - 557
[30] IMPACT OF HARM REDUCTION TREATMENT WITH OR WITHOUT PHARMACOTHERAPY ON CONCURRENT SUBSTANCE USE AMONG PEOPLE EXPERIENCING HOMELESSNESS AND ALCOHOL USE DISORDER
Mostofi, N.
Collins, S. E.
JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 290 - 290

← 1 2 3 4 5 →